BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6755207)

  • 21. Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule).
    Proctor SJ; Finney R; Walker W; Thompson RB
    Postgrad Med J; 1981 Jan; 57(663):19-22. PubMed ID: 6944694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot study.
    Mahoney DH; Camitta BM; Leventhal BG; Shuster JJ; Civin CJ; Ganick DJ; Lauer SJ; Steuber CP; Kamen BA
    Cancer; 1995 May; 75(10):2623-31. PubMed ID: 7736409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse.
    Kung FH; Nythan WL; Cuttner J; Falkson G; Lanzkowsky P; Del Duca V; Nawabi IU; Koch K; Pluess H; Freeman A; Burgert EO; Leone LA; Ruymann F; Patterson RB; Degnan T; Hakami N; Pajak TF; Holland J
    Cancer; 1978 Feb; 41(2):428-34. PubMed ID: 272945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
    Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R
    Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498
    [No Abstract]   [Full Text] [Related]  

  • 25. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
    Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
    N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chance of a second remission in acute juvenile lymphoblastic leukemia with favorable prognosis].
    Feldges A; Imbach P; Lüthy A; Plüss HJ; Sartorius J; Wyss M; Wagner HP
    Schweiz Med Wochenschr; 1982 Jul; 112(30):1070-3. PubMed ID: 6956975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclophosphamide (NSC-26271) maintenance therapy after a second remission of childhood acute lymphoblastic leukemia: comparative clinical trial (standard dose versus intermittent high dose versus cyclophosphamide plus cytosine arabinoside (NSC-63878)).
    Albo V; Movassaghi N; Sitarz AL; Hammond D; Weiner J; Reed A
    Cancer Chemother Rep; 1975; 59(6):1097-102. PubMed ID: 769949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    Eden OB; Lilleyman JS; Richards S; Shaw MP; Peto J
    Br J Haematol; 1991 Jun; 78(2):187-96. PubMed ID: 2064956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy.
    Lay HN; Ekert H; Colebatch JH
    Cancer; 1975 Oct; 36(4):1220-2. PubMed ID: 1058044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
    Dolan G; Lilleyman JS; Richards SM
    Arch Dis Child; 1989 Sep; 64(9):1231-4. PubMed ID: 2684039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the results of treatment of lymphoblastic leukemia in children by different methods].
    Derulska D; Rokicka-Milewska R; Skrobowska-Woźniak A; Makowska K; Kansy J
    Pediatr Pol; 1981 Sep; 56(9):985-92. PubMed ID: 6948273
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
    Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
    Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
    [No Abstract]   [Full Text] [Related]  

  • 34. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
    Smithson WA; Gilchrist GS; Burgert EO
    Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of acute lymphoblastic leukaemia in adults.
    Barnett MJ; Greaves MF; Amess JA; Gregory WM; Rohatiner AZ; Dhaliwal HS; Slevin ML; Biruls R; Malpas JS; Lister TA
    Br J Haematol; 1986 Nov; 64(3):455-68. PubMed ID: 3466641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of prednisolone, vincristine, methotrexate and 6-mercaptopurine vs. 6-mercaptopurine and prednisone maintenance therapy in childhood acute leukemia: a Southwest Oncology Group Study.
    Berry DH; Fernbach DJ; Herson J; Pullen J; Sullivan MP; Vietti TJ
    Cancer; 1980 Sep; 46(5):1098-1103. PubMed ID: 7011531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermittent combined chemotherapy with doxorubicin in recurrent childhood acute lymphoblastic leukemia.
    Ward Platt MP; Mott MG; Eden OB
    Med Pediatr Oncol; 1982; 10(6):563-8. PubMed ID: 6960230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
    Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ
    Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.